Cannabis company Heritage Cannabis Holdings Corp. (CSE:CANN) (OTCQX:HERTF) reported Wednesday that a company in which it holds a 30% non-controlling interest – Endocanna Health - has entered into a strategic partnership with OMNI Medical Services. OMNI is a multi-state operator of medical cannabis clinics, evaluations, research, pain management and online pharmacy services.
Under the partnership, OMNI is preparing a major study in collaboration with Endocanna to determine the best strain of plant-based medicines for patients by analyzing their endocannabinoid system. Endocanna’s EndoDNA test kits analyze essential biomolecules in the human endocannabinoid system to formulate and identify the ratios of CBD and cannabis the body metabolizes most effectively. The research will also explore optimal methods of consumption and dosing based on metabolic function and drug-to-drug interactions.
